510(k) Report

510(k) · Cleared

Cleared

OrthoGold 100

K182682510(k) TraditionalCleared Dec 21, 201886-day reviewClass I21 CFR 890.5660

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Tissue Regeneration Technologies · ISA Massager, Therapeutic, Electric

Cleared on Dec 21, 2018 as substantially equivalent to K081541 (Asclepion Laser Technologies GmbH, 2009) after an 86-day review. Its family tree reaches back 1 generation to 2009.

Decided
Dec 21, 2018
Review
86 days
Class
Class I
Product code
ISA
Recalls
None
Predicates
1

Its longest line of descent runs back 1 generation to K081541 (2009). No later device cites it as a predicate yet.

K081541 · Dermablate Effect · Asclepion Laser Technologies GmbH · 20092005201020152020
  1. Root · 1 generation backK081541 Dermablate EffectAsclepion Laser Technologies GmbH · 2009
  2. This deviceK182682 OrthoGold 100Tissue Regeneration Technologies · 2018
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−1K081541Dermablate EffectAsclepion Laser Technologies GmbH2009—
0 (this device)K182682OrthoGold 100Tissue Regeneration Technologies2018—
FIG. 1 — Lineage of K182682, 2009–2018Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in ISA? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new ISA device

  1. #1 K243488 Vmat Proscore 13.0 · 15 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K081541Dermablate Effect
Summary page 4
…): Manufacturer Device Name 510(k) Number Procode Class Asclepion Laser Dermablate Effect K081541 ISA I Technologies GmbH Indications for Use The OrthoGold 100™ is intended for the activation of connective…
Asclepion Laser Technologies GmbH2009—

Also cleared against K081541: 5 other devices →

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • Its one ancestor has no recall.
  • 5 other devices also cite its predicate K081541.

How does its category compare?

All ISA devices

ISA Massager, Therapeutic, Electric: FDA decisions, review times, recalls and adverse event reports over 20 years. 2018, this device’s year, is highlighted.

FDA decisions per year · ISA

1in 2025

2018: 22021: 12022: 22023: 22024: 12025: 1
2007high 2 (2018) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · ISA

Too few ISA 510(k)s in any year since 2007 to give a median.

Recalls per year · ISA

2in 2025

2008: 12011: 12025: 22026 (partial year): 1
2007high 2 (2025) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · ISA

16in 2025

2007: 22008: 102009: 32010: 12011: 32012: 22013: 52014: 62015: 62016: 122017: 62018: 22019: 62020: 62021: 32022: 82023: 142024: 132025: 16
2007high 16 (2025) · low 1 (2010)2025

MAUDE reports naming product code ISA, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—02
20080—110
20090—03
20100—01
20110—13
20120—02
20130—05
20140—06
20150—06
20160—012
20170—06
20182—02
20190—06
20200—06
20211—03
20222—08
20232—014
20241—013
20251—216
20260—1—

What is it indicated for?

The OrthoGold 100 is intended for the activation of connective tissue.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K182682: OrthoGold 100.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K182682

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026